MedPath

A study to compare efficacy of plain tap water iontophoresis versus iontophoresis using 1% aluminium chloride solution in palmoplantar hyperhidrosis

Not Applicable
Conditions
Health Condition 1: L745- Focal hyperhidrosis
Registration Number
CTRI/2019/06/019532
Lead Sponsor
MGM Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients having moderate to severe palmoplantar hyperhidrosis.

2.Patients willing to undergo treatment and come for follow up.

Exclusion Criteria

1.Patients who have a permanent pacemaker in heart.

2.Pregnant women & women who are planning to become pregnant.

3.Patients who have a metal implant in body.

4.Patients with medical conditions that is associated with hyperhidrosis eg. Hyperhidrosis, DM, Parkinsonism, spinal cord injury, anxiety, alcoholism, menopause.

5.Patients on any treatment with a drug that would affect sweating eg. Thyroxin, anxiolytics, topical aluminium chloride,

6.Patients with cardiac conditions e.g. Arrhythmias, or low respiratory reserve, congestive cardiac failure.

7.Patients who have any cuts, abrasions, eczema or infections over palms and soles.

8.Patients who have received previous treatment for hyperhidrosis, eg. Botulinum toxin, Sympathectomy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the efficacy of plain tap water iontophoresis versus iontophoresis using 1% aluminium chloride solution in patients of palmoplantar huperhidrosisTimepoint: Thrice weekly for 6 weeks then weekly for 4 weeks
Secondary Outcome Measures
NameTimeMethod
To study adverse effects of plain tap water iontophoresis and iontophoresis usig 1% aluminium chloride solutionTimepoint: Thrice weekly for 6 weeks then weekly for 4 weeks
© Copyright 2025. All Rights Reserved by MedPath